SHENZHEN KANGTAI B revenue breakdown overview

SHENZHEN KANGTAI B revenue for the last year amounted to 2.65 B CNY, the most of which — 2.55 B CNY — came from its highest performing source at the moment, Independent Products - Non-immunization Program Vaccines, the year earlier bringing 3.44 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought SHENZHEN KANGTAI B 2.65 B CNY, and the year before that — 3.48 B CNY.